Why the study?
Detecting Acute Coronary Syndrome in patients with chest pain is critical because 20% of emergency consultations for chest pain are diagnosed with acute myocardial infarction.
In patients presenting with ischemic chest pain in the emergency department, optimal management involves risk stratification, pharmacological therapy with P2Y12 inhibitors, and timely coronary intervention within 12 to 24 hours.
Answers are grounded in this paper and cite their sources.
Review of emergency interventions for ischemic chest pain is hypothesis-generating; leaves open need for higher-quality trials before any practice impact.
Chest pain is sometimes the reflection of minor pathologies, but in others, it is the expression of serious situations. The most important aspect in patients with chest pain is to detect the presence of Acute Coronary Syndrome since 20% of the consultations of the hospital emergency services for chest pain are diagnosed with acute myocardial infarction. The general objective is to evaluate the scientific evidence on interventions and treatment in patients with ischemic chest pain in the emergency services. The bibliographic search was carried out in the period of time between November 2019 and May 2020, finally a total of 24 articles were selected. The results show that DT caused by SCA can be treated pharmacologically with the new P2Y12 inhibitors, although it is not recommended that the treatment be exclusively pharmacological. The optimal time to initiate other treatment strategies such as coronography and coronary intervention is 12 to 24 hours.
No takes yet. Share an insight, caveat, or question.
Álvaro Astasio-Picado (2021) conducted a review in Ischemic chest pain / Acute Coronary Syndrome. Management of ischemic chest pain was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: